By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
Pre-election peek into Crown books shows bigger 2017 surplus, smaller ones later
Countdown 2017 profit falls on more expensive dairy, earthquake costs
A2 Milk triples annual profit, mulls special dividend; stock jumps to record
UPDATE: Air New Zealand annual earnings fall 21% in competitive market, hikes dividend
Genoapay founder gets $1M infusion, aims to build disruptive $1B payment platform
SLI changes strategy as retailers resist multiple e-commerce implementations, costs
August 23rd Morning Report
FIRST CUT: Air New Zealand annual earnings fall 21% in competitive market, hikes dividend
Vero to appeal regulator's rejection of Tower takeover
NZ dollar falls as greenback gains ahead of Jackson Hole summit, Prefu looms